Status:
WITHDRAWN
Assessing Efficacy of the Rothman Index
Lead Sponsor:
Yale University
Collaborating Sponsors:
PeraHealth
Conditions:
Inpatients Who Generate at Least Two Rothman Index Scores
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to assess the efficacy of the Rothman Index in combination with a set of recommended-use protocols to improve rates of mortality and/or rates of discharge to hospice care in hos...
Detailed Description
The Rothman Index (RI), created by PeraHealth, Inc., is a clinical support system used to recognize the early stages of clinical deterioration. It uses time-updated physiological data (vital signs, la...
Eligibility Criteria
Inclusion
- Adults inpatients greater than or equal to 18 years of age
- Admitted to any inpatient unit at two study sites within the Yale New Haven Health System
- Has generated at least 2 Rothman Index scores during the present hospital admission
Exclusion
- Prior admission in which patient was randomized
- Patient has opted out of electronic health record consent
- Patient in observation status
- Patient admitted to hospice service
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04403737
Start Date
November 1 2021
End Date
June 1 2023
Last Update
February 15 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Greenwich Hospital
Greenwich, Connecticut, United States, 06830
2
Lawrence + Memorial Hospital
New London, Connecticut, United States, 06320